Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Interest Expenses (2020 - 2025)

Rapid Micro Biosystems' Interest Expenses history spans 5 years, with the latest figure at $673000.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 5508.33% to $673000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 4534.78% increase, with the full-year FY2025 number at $1.1 million, up 2625.0% from a year prior.
  • Interest Expenses hit $673000.0 in Q4 2025 for Rapid Micro Biosystems, up from $393000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for RPID hit a ceiling of $932000.0 in Q1 2021 and a floor of $10000.0 in Q2 2022.
  • Historically, Interest Expenses has averaged $376000.0 across 4 years, with a median of $206000.0 in 2021.
  • Biggest five-year swings in Interest Expenses: tumbled 98.92% in 2022 and later skyrocketed 5508.33% in 2025.
  • Tracing RPID's Interest Expenses over 4 years: stood at $19000.0 in 2021, then crashed by 47.37% to $10000.0 in 2022, then increased by 20.0% to $12000.0 in 2024, then skyrocketed by 5508.33% to $673000.0 in 2025.
  • Business Quant data shows Interest Expenses for RPID at $673000.0 in Q4 2025, $393000.0 in Q3 2025, and $12000.0 in Q4 2024.